Today's Top Health News Story

U.S. senators seek ban on pesticide chlorpyrifos

NEW YORK (Reuters) - A group of Democratic senators hopes to ban a pesticide the U.S. government has greenlighted for use, according to a bill unveiled on Tuesday in a challenge to Republican President Donald Trump's push to loosen environmental regulations. Learn More


More Top Health Stories

Lilly signals long delay for arthritis drug, shares fall

(Reuters) - Eli Lilly and Co on Tuesday outlined a likely multi-year delay for its experimental rheumatoid arthritis drug with blockbuster sales potential, and disappointed investors sent its shares down nearly 4 percent. More »


Myanmar reports outbreak of H5N1 bird flu on poultry farm: OIE

PARIS (Reuters) - Myanmar has reported an outbreak of highly pathogenic H5N1 bird flu on a farm in the southern Tanintharyi Region, the Paris-based World Organisation for Animal Health (OIE) said on Tuesday, citing a report from Myanmar's livestock ministry. More »


Yemen cholera epidemic slowing after infecting 400,000

GENEVA (Reuters) - Yemen's cholera outbreak is set to hit 400,000 cases on Tuesday but there are signs the three-month-old epidemic is slowing, according to World Health Organization data analyzed by Reuters. More »


HCA Healthcare slumps as profit misses on weak patient volumes

(Reuters) - HCA Healthcare Inc's profit missed estimates for the second straight quarter, hurt by higher expenses and weaker-than-expected patient volumes, and the hospital operator cut its full-year earnings forecast, sending its shares down 4 percent. More »


Insulin resistance linked to lower bone density

(Reuters Health) - Decreasing sensitivity to insulin - often associated with obesity and eventual type 2 diabetes - may also cause young adults to have lower bone mass at a time of life when it should be at its peak, Korean researchers say. More »


After strong quarter, Biogen rolls out growth strategy

(Reuters) - Biogen Inc laid out long-term plans to strengthen its mainstay multiple sclerosis (MS) business, develop more neuroscience drugs and shop for late-stage assets, after reporting robust second-quarter results on Tuesday. More »


Slight drop in measles vaccinations could triple infections in U.S. kids

(Reuters Health) - Just a 5 percent decline in measles vaccination rates could triple the number of young children who get infected with the virus in the U.S., according to a study highlighting the risks of parents refusing to vaccinate their kids. More »


Dozens of U.S. clinics sell unproven stem cell therapies for heart failure

(Reuters Health) - Stem cell therapy isn’t approved to treat heart failure in the U.S., but dozens of clinics nationwide advertise the treatments anyway, often charging thousands of dollars for procedures that may not be safe or effective, a new study suggests. More »


U.S. jury finds AbbVie liable for misrepresentation in AndroGel verdict

NEW YORK (Reuters) - A federal jury in Chicago on Monday found AbbVie Inc fraudulently misrepresented the risks of its testosterone replacement drug AndroGel and ordered the drugmaker to pay $150 million in punitive damages. More »


News, Photo and Web Search